Ivim Health vs Oak Longevity: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Ivim Health beats Oak Longevity overall, scoring 7.9/10 vs 7.5/10. Oak Longevity is more affordable at $133/mo vs $150/mo. Choose Ivim Health for users who want personalized dosing with frequent provider ch. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.
A side-by-side look at Ivim Health and Oak Longevity to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Ivim Health
#8 of 53Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.
Visit Ivim HealthOak Longevity
#25 of 53Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.
Visit Oak Longevity| Feature | Ivim Health | Oak Longevity |
|---|---|---|
| Our Score | 7.9/10 | 7.5/10 |
| Starting Price | $150/mo | $133/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want personalized dosing with frequent provider check-ins | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) |
| Watch out for | The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses | Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct |
| Ranking | #8 | #25 |
| Get started | Visit Ivim Health | Visit Oak Longevity |
Pros & Cons Compared
Ivim Health
Pros
- +$75/mo starting price is among the lowest in the market for a program with actual provider oversight
- +Bi-weekly provider check-ins included, more frequent than most platforms at this price point
- +Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
- +Both brand-name and compounded available, with the option to switch based on response
Cons
- −The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses
- −No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront
Oak Longevity
Pros
- +$133/mo for compounded semaglutide is among the cheapest entries on the market, Sesame Care ($99) is lower, but Oak undercuts most mid-tier platforms
- +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
- −No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
- −The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
- −The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits
Our Verdict
Ivim Health edges out Oak Longevity with a score of 7.9/10 vs 7.5/10. If budget is your priority, Oak Longevity starts at $133/mo compared to Ivim Health's $150/mo. Choose Ivim Health if you want: users who want personalized dosing with frequent provider check-ins. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Ivim Health nor Oak Longevity feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Ivim Health or Oak Longevity tend to look at next.
- Ivim Health vs Sprout Health$199/mo
- Ivim Health vs bmiMD$119/mo
- Ivim Health vs Found$129/mo
- Oak Longevity vs Found$129/mo
- Oak Longevity vs GobyMeds$169/mo
- Oak Longevity vs bmiMD$119/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.